Shukra (SHUKRAPHAR) | Financial Analysis & Statements
Shukra Pharmaceuticals Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
53.9M
Gross Profit
46.2M
85.71%
Operating Income
5.3M
9.86%
Net Income
10.3M
19.10%
EPS (Diluted)
₹0.02
Balance Sheet Metrics
Total Assets
867.7M
Total Liabilities
239.3M
Shareholders Equity
628.4M
Debt to Equity
0.38
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Shukra Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 325.9M | 745.7M | 588.3M | 204.9M | 112.0M |
| Cost of Goods Sold | 81.1M | 444.9M | 453.2M | 103.5M | 27.7M |
| Gross Profit | 244.8M | 300.9M | 135.2M | 101.4M | 84.3M |
| Gross Margin % | 75.1% | 40.3% | 23.0% | 49.5% | 75.3% |
| Operating Expenses | |||||
| Research & Development | 1.7M | 1.3M | 1.2M | 943.0K | 529.0K |
| Selling, General & Administrative | 26.8M | 28.0M | 6.1M | 4.4M | 2.3M |
| Other Operating Expenses | 19.9M | 16.2M | 19.9M | 11.1M | 18.3M |
| Total Operating Expenses | 48.4M | 45.5M | 27.2M | 16.4M | 21.2M |
| Operating Income | 97.2M | 173.5M | 35.3M | 12.2M | 2.4M |
| Operating Margin % | 29.8% | 23.3% | 6.0% | 6.0% | 2.1% |
| Non-Operating Items | |||||
| Interest Income | 14.8M | 5.6M | 639.0K | 314.0K | 467.0K |
| Interest Expense | 5.2M | 2.8M | 2.6M | 2.8M | 130.0K |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 133.4M | 198.8M | 44.4M | 10.2M | 978.0K |
| Income Tax | 37.6M | 13.5M | 432.0K | 2.7M | -902.0K |
| Effective Tax Rate % | 28.2% | 6.8% | 1.0% | 26.3% | -92.2% |
| Net Income | 95.8M | 185.4M | 44.1M | 7.5M | 1.9M |
| Net Margin % | 29.4% | 24.9% | 7.5% | 3.7% | 1.7% |
| Key Metrics | |||||
| EBITDA | 168.6M | 219.6M | 61.0M | 29.3M | 17.8M |
| EPS (Basic) | ₹0.22 | ₹16.93 | ₹6.55 | ₹0.25 | ₹0.06 |
| EPS (Diluted) | ₹0.22 | ₹16.93 | ₹6.55 | ₹0.25 | ₹0.06 |
| Basic Shares Outstanding | 437879440 | 10946986 | 6725968 | 30095360 | 30095360 |
| Diluted Shares Outstanding | 437879440 | 10946986 | 6725968 | 30095360 | 30095360 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Shukra Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 121.2M | 99.8M | 39.7M | 2.9M | 5.0M |
| Short-term Investments | 121.2M | 99.8M | - | - | 34.3M |
| Accounts Receivable | 87.7M | 245.1M | 301.9M | 74.0M | 97.5M |
| Inventory | 99.5M | 23.1M | 31.6M | 39.5M | 16.8M |
| Other Current Assets | 1.2M | 796.0K | 132.2M | 1.0K | 1.0K |
| Total Current Assets | 654.3M | 562.3M | 530.7M | 158.7M | 160.6M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 194.0M | 3.6M | 3.6M | 3.3M | 3.3M |
| Goodwill | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | -1.0K | 357 | 340 | 12.0K | -1.3K |
| Total Non-Current Assets | 213.4M | 216.0M | 218.9M | 192.4M | 195.5M |
| Total Assets | 867.7M | 778.4M | 749.7M | 351.1M | 356.1M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 92.2M | 72.2M | 336.2M | 85.9M | 53.3M |
| Short-term Debt | 10.6M | 5.0M | 13.1M | 2.5M | 0 |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 42.7M | 10.1M | -1.0K | 1.0K | - |
| Total Current Liabilities | 172.8M | 141.5M | 425.1M | 123.8M | 70.3M |
| Non-Current Liabilities | |||||
| Long-term Debt | 31.1M | 26.6M | 37.7M | 31.3M | 97.7M |
| Deferred Tax Liabilities | 34.1M | 32.7M | 32.9M | 32.6M | 32.0M |
| Other Non-Current Liabilities | 2.0K | 1.0K | 1.1M | -2.0K | - |
| Total Non-Current Liabilities | 66.5M | 60.4M | 71.6M | 63.9M | 129.7M |
| Total Liabilities | 239.3M | 202.0M | 496.7M | 187.6M | 200.1M |
| Equity | |||||
| Common Stock | 437.9M | 109.5M | 39.1M | 15.7M | 15.7M |
| Retained Earnings | 143.0M | 375.6M | 191.1M | 147.8M | 140.3M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 628.4M | 576.4M | 253.0M | 163.5M | 156.0M |
| Key Metrics | |||||
| Total Debt | 41.8M | 31.5M | 50.8M | 33.8M | 97.7M |
| Working Capital | 481.4M | 420.8M | 105.7M | 35.0M | 90.3M |
Balance Sheet Composition
Shukra Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 133.4M | 198.8M | 44.4M | 10.2M | 978.0K |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -57.7M | 1.5M | -287.2M | 22.3M | -487.0K |
| Operating Cash Flow | 66.8M | 195.1M | -245.2M | 35.0M | 154.0K |
| Investing Activities | |||||
| Capital Expenditures | -27.4M | -17.6M | -44.9M | -15.5M | -17.9M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | 0 |
| Investing Cash Flow | -27.4M | -17.6M | -44.9M | -15.5M | -17.9M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -43.8M | -702.0K | -728.0K | - | - |
| Debt Issuance | 4.6M | - | 6.4M | 0 | 17.4M |
| Debt Repayment | - | -11.1M | - | -63.9M | 0 |
| Financing Cash Flow | -39.2M | 126.9M | 52.0M | -63.9M | 17.4M |
| Free Cash Flow | 51.8M | -69.6M | -13.2M | 64.4M | -12.5M |
| Net Change in Cash | 145.0K | 304.4M | -238.2M | -44.4M | -351.0K |
Cash Flow Trend
Shukra Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
770.20
Price to Book
22.86
Price to Sales
21.46
PEG Ratio
1.39
Profitability Ratios
Profit Margin
45.16%
Operating Margin
67.87%
Return on Equity
15.24%
Return on Assets
11.04%
Financial Health
Current Ratio
3.80
Debt to Equity
5.71
Beta
0.94
Per Share Data
EPS (TTM)
₹-0.20
Book Value per Share
₹1.38
Revenue per Share
₹0.88
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| SHUKRAPHAR | 13.9B | 770.20 | 22.86 | 15.24% | 45.16% | 5.71 |
| Sun Pharmaceutical | 3.9T | 36.73 | 5.15 | 15.08% | 19.21% | 6.68 |
| Divi's Laboratories | 1.7T | 67.11 | 10.82 | 14.64% | 24.04% | 0.58 |
| Sun Pharma Advanced | 46.7B | -13.65 | -13.55 | 157.88% | -53.22% | -1.21 |
| Innova Captab | 41.4B | 31.20 | 4.05 | 13.37% | 8.85% | 32.95 |
| Gujarat Themis | 35.4B | 73.73 | 13.36 | 19.64% | 29.99% | 27.04 |
Financial data is updated regularly. All figures are in the company's reporting currency.





